Med school enrolls first U.S. patient in global trial to treat childhood chronic kidney disease
If chronic kidney disease progression is not slowed, patients eventually face being put on dialysis or may require a kidney transplant.
Read MoreIf chronic kidney disease progression is not slowed, patients eventually face being put on dialysis or may require a kidney transplant.
Read MoreNovo argues that Eli Lilly’s advertisements for its GLP-1 drugs are “deliberately simple and deliberately false,” causing harm to both Novo and “the patients Lilly deceives.”
Read MoreThe deal comes about three months after President Donald Trump signed an executive order directing the U.S. Food and Drug Administration and other federal agencies to speed research and loosen restrictions on psychedelic drug treatments for mental health conditions.
Indianapolis-based Elevance Health reported a second-quarter profit of nearly $1.5 billion and raised its full-year earnings guidance, but its shares still sank more than 10% on Wednesday morning.
In the complaint, Tampa General Hospital calls Eli Lilly and Co.’s move “unconscionable and immoral.”
The NSF IMPACT Engine in Indiana will work to connect more than 170 partners to accelerate development of musculoskeletal innovation.
Steve Hoerter, who was previously executive chairman of the company’s board of directors, has succeeded Kent Hawryluk as CEO and board chair.
The appellate court held that Teva plausibly alleged that Lilly breached the two companies’ 2018 settlement agreement, which stipulated that Lilly would not interfere with Teva getting approval for a generic version of Lilly’s osteoporosis drug, Forteo.
For its biggest project, Parkview plans to break ground this month on a $200 million hospital and medical office building in West Lafayette on land it acquired from the Purdue Research Foundation.
In his new job, Dr. Ram Yeletti will focus on expanding Parkview’s specialty care services and physician network in its new markets.
The nonprofit will collaborate with five health networks to launch the Maternal & Infant Health Scorecard.
The Hydrocephalus Association will host HA Connect, the National Conference on Hydrocephalus from July 23-25 at the JW Marriott Indianapolis.
The payment is an effort by Elevance to settle a dispute in which the company is accused of overcharging Medicare for years.
The 170-acre northeast-side Indianapolis campus is composed of 21 buildings and serves as one of the company’s two global hubs.
The health system received approval from the U.S. Food and Drug Administration in January for the IU Health 3D Print Studio.
In October, Corteva’s board of directors unanimously approved a plan to separate the company into two independent, publicly traded businesses.
The funding commitment from Telamon Corp. CEO Stanley Chen and his wife, Allison, will be doubled to $2 million by a dollar-by-dollar match by IU Health.
Elanco Animal Health Inc. is among the companies taking a leading role in combating the re-emergence of deadly New World screwworm that was pushed out of the United States six decades ago.
Indianapolis Mayor Joe Hogsett in 2022 committed to the creation of a mobile crisis response team led by clinicians rather than police. Four years later, the teams are in place, but they’re barely being used.
A cluster of medical services facilities south of Interstate 69’s Exit 210 in Fishers represents almost a billion dollars of industry investment, according to Mayor Scott Fadness.
The move to remove Meridian from Anthem’s Medicaid network will take effect July 25 and impact about 18,000 patients.
Stat reported that Lilly and the FDA allowed a 79-year-old man to gain access to the retatrutide through the FDA’s compassionate use program.